OAM
ACOR
Oxford Asset Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-234,240
| Closed | -$672K | – | 2183 |
|
|
2019
Q3 | $672K | Sell |
234,240
-89,134
| -28% | -$256K | 0.02% | 1130 |
|
|
2019
Q2 | $2.48M | Buy |
323,374
+299,272
| +1,242% | +$2.3M | 0.05% | 549 |
|
|
2019
Q1 | $320K | Buy |
+24,102
| New | +$320K | 0.01% | 1392 |
|
|
2018
Q4 | – | Sell |
-39,677
| Closed | -$779K | – | 2192 |
|
|
2018
Q3 | $779K | Sell |
39,677
-39,633
| -50% | -$778K | 0.02% | 1121 |
|
|
2018
Q2 | $2.27M | Buy |
79,310
+31,436
| +66% | +$899K | 0.04% | 593 |
|
|
2018
Q1 | $1.13M | Sell |
47,874
-68,343
| -59% | -$1.62M | 0.02% | 881 |
|
|
2017
Q4 | $2.62M | Buy |
116,217
+30,846
| +36% | +$696K | 0.06% | 443 |
|
|
2017
Q3 | $2.03M | Buy |
+85,371
| New | +$2.03M | 0.04% | 618 |
|
|
2017
Q2 | – | Sell |
-70,521
| Closed | -$1.48M | – | 1748 |
|
|
2017
Q1 | $1.48M | Sell |
70,521
-181,154
| -72% | -$3.8M | 0.04% | 640 |
|
|
2016
Q4 | $4.73M | Sell |
251,675
-133,258
| -35% | -$2.5M | 0.17% | 117 |
|
|
2016
Q3 | $8.04M | Buy |
384,933
+214,247
| +126% | +$4.47M | 0.25% | 95 |
|
|
2016
Q2 | $4.35M | Buy |
170,686
+142,679
| +509% | +$3.64M | 0.14% | 174 |
|
|
2016
Q1 | $741K | Sell |
28,007
-6,681
| -19% | -$177K | 0.02% | 540 |
|
|
2015
Q4 | $1.49M | Sell |
34,688
-103,697
| -75% | -$4.46M | 0.04% | 451 |
|
|
2015
Q3 | $3.67M | Buy |
138,385
+15,271
| +12% | +$405K | 0.12% | 183 |
|
|
2015
Q2 | $4.1M | Sell |
123,114
-138,009
| -53% | -$4.6M | 0.11% | 210 |
|
|
2015
Q1 | $8.69M | Buy |
261,123
+167,102
| +178% | +$5.56M | 0.22% | 99 |
|
|
2014
Q4 | $3.82M | Sell |
94,021
-4,008
| -4% | -$163K | 0.08% | 252 |
|
|
2014
Q3 | $3.32M | Buy |
+98,029
| New | +$3.32M | 0.08% | 262 |
|